ALISO VIEJO, Calif., May 24 /PRNewswire-FirstCall/ -- Clarient, Inc. , a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced that it is scheduled to make an investor presentation at the Friedman, Billings, Ramsey 2007 Growth Conference at 12:50 p.m. ET on Thursday, May 31, 2007. The conference will be held at the Grand Hyatt New York Hotel, May 30 & 31.
A live webcast of the Company’s presentation at the conference will be available via a link provided at http://www.clarientinc.com/investor. An archived replay of the presentation will be available shortly after the presentation time for a period of 90 days.
About Clarient
Clarient combines innovative technologies with world class expertise to assess and characterize cancer. Clarient’s mission is to provide the services, resources and critical information to improve the quality and reduce the cost of patient care as well as accelerating the drug development process. The Company’s principal customers include pathologists, oncologists, hospitals and biopharmaceutical companies.
The rise of individualized medicine as the new direction in oncology has created the need for a centralized resource providing leading diagnostic technologies such as flow cytometry and molecular testing. Clarient is that resource, having created a state-of-the-art commercial cancer laboratory providing the most advanced oncology testing and drug development services available both onsite and over the web. Clarient is a Safeguard Scientifics, Inc. partner company. For more information, visit www.clarientinc.com.
About Safeguard
Safeguard Scientifics, Inc. , a holding company, builds value in growth-stage technology and life sciences businesses. Safeguard provides growth capital as well as a range of strategic, operating and management resources to our partner companies. Safeguard participates in growth buyout financings, including corporate spin-outs and management buyouts, expansion financings, industry consolidations and early-stage financings. www.safeguard.com
Contact: Matt Clawson John Baldissera Allen & Caron, Inc. BPC Financial Marketing (949) 474-4300 (800) 368-1217 matt@allencaron.com
Clarient, Inc.
CONTACT: Matt Clawson of Allen & Caron, Inc., +1-949-474-4300,matt@allencaron.com, for Clarient, Inc.; or John Baldissera of BPCFinancial Marketing, +1-800-368-1217, for Clarient, Inc.
